Inducing Cellular Senescence Using Defined Genetic Elements.
From: Gastroenterology Division, Department of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Methods in molecular biology (Clifton, N.J.)
- Publish Date: 2007
- ISSN: 1064-3745
- Volume: 371
- Issue:
- Pages: 167-78
- Medium: Print
- Language: English
- Citation (JAMA): Nakagawa Hiroshi, Opitz Oliver G, et al. Inducing Cellular Senescence Using Defined Genetic Elements.. Methods Mol. Biol. 2007;371:167-78
Abstract
Cellular senescence is generally defined as an irreversible state of G1 cell cycle arrest in which cells are refractory to growth factor stimulation. Cellular senescence can be induced through several different mechanisms. Primary mammalian cells display a finite life span, suggesting a mechanism that counts cell divisions. Those cells initially proliferate but eventually enter a state of permanent growth arrest, called replicative senescence. Erosion of telomeric DNA has emerged as a key factor in replicative senescence, which is antagonized during cell immortalization. Nevertheless, besides telomere shortening, there are other mechanisms inducing a growth arrest similar to the replicative senescencent phenotype. Oncogenic or mitogenic signals as well as DNA damage can induce such a phenotype of cellular senescence. All forms of cellular senescence share common signaling pathways and morphological features. Thereby, p53 seems to be essential for the senescence response. Many of these senescence inducing mechanisms can be experimentally recapitulated by the introduction of defined genetic elements. Replicative senescence due to telomere shortening can, for example, be induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras, or p16.
Mesh Headings (Keywords): Animals, Cell Aging, Cells, Cultured, Cyclin-Dependent Kinase Inhibitor p16, DNA Damage, G1 Phase, Genes, ras, Humans, Mice, Signal Transduction, Telomere, Tumor Suppressor Protein p53
Check for Full Text / PubMed Unique Identifier (PMID): 17634581
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.